4.3 Article Proceedings Paper

Development of omics-based clinical tests for prognosis and therapy selection: The challenge of achieving statistical robustness and clinical utility

Related references

Note: Only part of the references are listed.
Review Cardiac & Cardiovascular Systems

Risk prediction models: II. External validation, model updating, and impact assessment

Karel G. M. Moons et al.

HEART (2012)

Article Medicine, General & Internal

A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer

Christos Hatzis et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

Article Mathematical & Computational Biology

Biostatistical Considerations in Development of Biomarker-Based Tests to Guide Treatment Decisions

Gary M. Clark et al.

STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2011)

Article Oncology

Gene Expression-Based Prognostic Signatures in Lung Cancer: Ready for Clinical Use?

Jyothi Subramanian et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)

Editorial Material Oncology

Randomized Clinical Trials With Biomarkers: Design Issues

Boris Freidlin et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)

Editorial Material Oncology

Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers

Richard M. Simon et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)

Article Biochemical Research Methods

Prediction error estimation: a comparison of resampling methods

AM Molinaro et al.

BIOINFORMATICS (2005)

Review Oncology

Clinical trial designs for predictive marker validation in cancer treatment trials

DJ Sargent et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

Article Medicine, General & Internal

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

S Paik et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)